# Elite Value Audit — INV_EXP_005

**Device class:** 005
**Tier:** **REJECT**
**Criteria met:** 7/12
**Fatal attacks:** 0
**Timestamp:** 2026-08-16T03:44:13.227283+00:00

## Inventive Nucleus
005 inventive concept

## Claim
```
A cardiac pacemaker device for regulating heartbeats, comprising: A) a housing (A) having a structural requirement of being a sealed, waterproof container (structural_requirement); B) a sensor (B) for detecting heart activity, wherein the sensor (B) has a technical feature of being capable of detecting electrical signals (technical_feature) and a functional requirement of transmitting data to a control unit (functional_requirement); and C) a control unit (not shown) for generating pacing signals
```

## Economic Value Assessment
- **Customer problem:** Patients with irregular heartbeats require reliable cardiac pacing devices that can accurately detect heart activity and deliver appropriate pacing signals while being durable enough for long-term implantation.
- **Economic pain:** Current pacemakers face limitations in reliability, battery life, and the ability to accurately detect heart signals in various physiological conditions, leading to device replacements and additional medical interventions.
- **Current cost:** Average pacemaker implantation costs range from $10,000 to $50,000 per device (EVIDENCE|INFERENCE|HYPOTHESIS)
- **Value created:** Improved reliability, extended battery life, better signal detection accuracy, and reduced need for replacement surgeries.
- **Who pays:** Healthcare systems, insurance companies, and patients (through insurance premiums or out-of-pocket expenses)
- **Why they pay:** Reduction in total cost of ownership through fewer replacements, improved patient outcomes, and reduced hospital readmissions
- **Adoption barrier:** Regulatory approval process for medical devices is lengthy and expensive, requiring extensive clinical trials. Existing market players have established relationships with healthcare providers.
- **Value creation types:** COST_REDUCTION, PERFORMANCE_IMPROVEMENT, DURABILITY_ENHANCEMENT
- **Market size evidence:** INFERENCE
- **Market size basis:** Global cardiac pacemaker market was valued at approximately $6.5 billion in 2022 and is projected to grow at a CAGR of 5-7% based on industry reports

## Elite Criteria Scores (12)
| # | Criteria | Met | Confidence | Reasoning |
|---|---|---|---|---|
| 1 | A_large_expensive_problem | ✓ | EVIDENCE | Irregular heartbeats are a significant health issue requiring reliable cardiac pacing devices, with  |
| 2 | B_clear_economic_buyer | ✓ | EVIDENCE | Healthcare systems, insurance companies, and patients (through insurance premiums or out-of-pocket e |
| 3 | C_substantial_measurable_benefit | ✓ | INFERENCE | The invention offers three value creation types: COST_REDUCTION, PERFORMANCE_IMPROVEMENT, and DURABI |
| 4 | D_technically_meaningful_mechanism | ✗ | HYPOTHESIS | The claim describes basic components (housing, sensor, control unit) with standard features (waterpr |
| 5 | E_difficult_to_reproduce_without_the_invention | ✗ | HYPOTHESIS | The invention appears to describe fundamental pacemaker components and functions that could be readi |
| 6 | F_meaningful_structural_functional_relationship | ✗ | HYPOTHESIS | The claim only states basic relationships between components (sensor detects signals, control unit g |
| 7 | G_plausible_manufacturing_path | ✓ | INFERENCE | Given that pacemakers are already manufactured at scale, the components described (waterproof housin |
| 8 | H_manageable_regulatory_pathway | ✓ | INFERENCE | Cardiac pacemakers are already regulated medical devices with established FDA approval pathways (PMA |
| 9 | I_credible_validation_experiment | ✓ | INFERENCE | Standard pacemaker validation experiments (bench testing, animal studies, clinical trials) would be  |
| 10 | J_credible_patent_claim_space | ✗ | HYPOTHESIS | The claim appears to cover basic pacemaker functionality and components that may already be in the p |
| 11 | K_meaningful_difficulty_of_design-around | ✗ | HYPOTHESIS | Given the basic nature of the claimed features, competitors could likely design around this patent b |
| 12 | L_potential_for_platform_product_expansion | ✓ | INFERENCE | The basic pacemaker architecture described could potentially serve as a platform for additional feat |
| 13 | E_difficult_to_reproduce | ✗ | HYPOTHESIS | Not assessed |
| 14 | K_meaningful_design_around_difficulty | ✗ | HYPOTHESIS | Not assessed |
| 15 | L_platform_product_expansion_potential | ✗ | HYPOTHESIS | Not assessed |

## Rejection Patterns
**Matched:** generic_sensor_improvement, known_component_substitution
**New technical effect:** NONE

## Four-Attack Destruction Test
| Attack | Strength | Can Survive | Rationale |
|---|---|---|---|
| NOVELTY_102 | NONE | ✓ | None of the provided prior-art references disclose a cardiac pacemaker device with a sealed, waterpr |
| OBVIOUSNESS_103 | NONE | ✓ | None of the provided prior-art references disclose any cardiac pacemaker technology or related compo |
| ENABLEMENT_112 | NONE | ✓ | The claim describes a cardiac pacemaker with specific features (sealed waterproof housing, sensor fo |
| DESIGN_AROUND | MODERATE | ✓ | The easiest design around would be to create a cardiac pacemaker with a semi-permeable membrane hous |

## Prior-Art Search Provenance
- **Sources searched:** GOOGLE_PATENTS, PATSNAP_EUREKA, LENS_SCHOLARLY
- **Sources live:** LENS_SCHOLARLY
- **Total hits:** 6
- **Patent family normalization:** Applied (US/WO/EP/CN/JP/KR/AU collapsed)

## Tier Reasoning
Rejection patterns matched (['generic_sensor_improvement', 'known_component_substitution']) with no new technical effect

## Honest Disclosure
- LLM calls: 4
- Elapsed: 32.1s
- All economic numbers tagged: EVIDENCE | INFERENCE | HYPOTHESIS
- Human patent lawyer review remains a separate final act
- This audit may output STRONG_CANDIDATE_FOR_FILING but NEVER LEGALLY_PATENTABLE